BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34677686)

  • 1. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.
    Michel A; Dinger T; Darkwah Oppong M; Rauschenbach L; Deuschl C; Ahmadipour Y; Pierscianek D; Wrede K; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
    Acta Neurochir (Wien); 2022 Feb; 164(2):439-449. PubMed ID: 34677686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
    Michel A; Dinger TF; Santos AN; Pierscianek D; Darkwah Oppong M; Ahmadipour Y; Dammann P; Wrede KH; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
    J Neurooncol; 2022 Aug; 159(1):53-63. PubMed ID: 35672530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic value of treatment for brain metastases and the primary tumor in patients with breast cancer brain metastases.
    Wang Y; Ji Z; Lin FH; Wang XH; Wan-Ming H; He ZQ; Duan H; Guo CC; Zhang XH; Mou YG
    Clin Neurol Neurosurg; 2018 Jul; 170():43-46. PubMed ID: 29727800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
    Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
    Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
    Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
    World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
    Leone JP; Lee AV; Brufsky AM
    Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases from breast cancer.
    Santos J; Arantes J; Carneiro E; Ferreira D; Silva SM; Palma de Sousa S; Arantes M
    Clin Neurol Neurosurg; 2020 Oct; 197():106150. PubMed ID: 32920499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
    Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
    Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer brain metastases - A 12 year review of treatment outcomes.
    De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
    Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.
    Tabouret E; Metellus P; Tallet-Richard A; Figarella-Branger D; Charaffe-Jauffret E; Viens P; Gonçalves A
    Anticancer Res; 2013 May; 33(5):2159-67. PubMed ID: 23645770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
    Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases.
    Márquez-Ortiz RA; Contreras-Zárate MJ; Tesic V; Alvarez-Eraso KLF; Kwak G; Littrell Z; Costello JC; Sreekanth V; Ormond DR; Karam SD; Kabos P; Cittelly DM
    Clin Cancer Res; 2021 Nov; 27(22):6209-6221. PubMed ID: 34544797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
    Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
    Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Xie N; Tian C; Wu H; Yang X; Liu L; Li J; Xiao H; Gao J; Lu J; Hu X; Cao M; Shui Z; Tang Y; Wang X; Yang J; Hu ZY; Ouyang Q
    Ther Adv Med Oncol; 2020; 12():1758835920915305. PubMed ID: 32499836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
    Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
    Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
    Front Oncol; 2022; 12():905065. PubMed ID: 35832552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
    J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast Cancer Res Treat; 2021 Apr; 186(2):453-462. PubMed ID: 33392845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
    Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.